• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Fresh from IPO, Acelyrin's lead drug fails clinical trial

cafead

Administrator
Staff member
  • cafead   Sep 12, 2023 at 12:02: PM
via Acelyrin has been flying high in the wake of an unusually large initial public offering (IPO) in May, but came down to earth with a bump today after a failed clinical trial poleaxed its share price.

article source
 

<